Spadinsword Spadin, a natural peptide derived from the sortilin precursor, has emerged as a significant molecule in the field of neuroscience, particularly for its potential as a rapid-acting antidepressant. This 17-amino acid peptide has garnered attention for its ability to selectively block TREK-1 (TWIK-related K+ channel) activity, a mechanism that appears central to its therapeutic effectsPE-22-28 Peptide: Depression and Neurogenesis Research. The identification of spadin represents a new conceptual approach to treating depression, offering a distinct alternative to traditional antidepressant medications.
Spadin originates from the maturation of sortilin, also known as neurotensin receptor 3 (NTS3). This endogenous peptide is released into the bloodstream from a propeptide. Its primary known function is as a potent TREK-1 channel blockerSpadin TFA is a high-purity neuroprotective peptidefor neuroscience research, offering reliable performance and quality from APExBIOenhance your studies .... TREK-1 channels are outwardly rectifying potassium channels that play a role in neuronal excitability and neurotransmitter release. By inhibiting these channels, spadin appears to modulate neuronal activity in key brain regions, such as the dorsal raphe nucleus, leading to enhanced 5-HT (serotonin) neurotransmission. This targeted action on TREK-1 channels is considered a novel mechanism for antidepressant therapy, differentiating it from many existing treatments.
The most compelling aspect of spadin is its potential as an antidepressant. Research has indicated that spadin can induce a potent antidepressant effect, with some studies suggesting a rapid onset of action, potentially within days, compared to weeks for conventional antidepressants. This fast-acting nature makes spadin a promising candidate for individuals who do not respond well to existing treatments or require quicker relief from depressive symptoms.PE 22-28 (8mg) - peptide with antidepressant properties. The scientific community views spadin as a significant discovery, with its identification marking a new era in the search for effective antidepressant agents.
Spadin is a subject of ongoing research, with scientists exploring its full therapeutic potential and developing analogs for enhanced efficacy and specificity. Studies have focused on validating the "spadin concept" for depression treatment and investigating shortened analogs, such as PE 12-28 and PE 22-28, which also exhibit potent antidepressant properties and TREK-1 inhibitory activityPE 22-28 has a high potential for use in the treatment of depression, regulation of neuro- and synaptogenesis, with increased efficacy and rapid action.. These analogs are being developed to optimize therapeutic outcomes and potentially improve pharmacokinetic profiles.作者：J Veyssiere·2015·被引用次数：17—Spadin is a 17 amino acid peptidewhich was designed from a 44 amino acid peptide (called PE) released by furin in the late Golgi apparatus ... Beyond its antidepressant role, spadin is also recognized as a neuroprotective peptide, supporting its utility in neuroscience research.Spadin, a Sortilin-Derived Peptide, Targeting Rodent TREK-1 Channels
It is important to distinguish spadin peptide from other terms that share similar spellingsSpadin (Human). For instance, "Spadin" also refers to an insecticide product, which is unrelated to the peptide discussed here.作者：J Mazella·2010·被引用次数：214—We demonstrate thatspadin, a natural peptide derived from a propeptide released in blood, is able to block the TREK-1 channel activity and has an ... The scientific literature consistently refers to spadin as a peptide derived from sortilin and acting on TREK-1 channels, underscoring its specific biological and pharmacological context.
In conclusion, spadin peptide represents a significant advancement in the understanding and potential treatment of depression. Its unique mechanism of action as a TREK-1 channel blocker and its demonstrated rapid antidepressant effects position it as a molecule of considerable interest for future therapeutic development in neuroscience2024年7月9日—Spadin is an endogenous peptidederived from sortilin (a NTS3 receptor), selectively inhibiting TREK-1 channel, which is an effective treatment ....
Join the newsletter to receive news, updates, new products and freebies in your inbox.